These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6164177)

  • 21. The immunocytochemical detection of growth hormone and prolactin in human prostatic tissues.
    Harper ME; Sibley PE; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1981; 75B():115-28. PubMed ID: 6172800
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostate specific antigen in benign prostatic hyperplasia: purification and characterization.
    Chen Z; Chen H; Stamey TA
    J Urol; 1997 Jun; 157(6):2166-70. PubMed ID: 9146608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer.
    Vallbo C; Wang W; Damber JE
    BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ion exchange chromatography of free amino acids in aqueous fluid and lens of the human eye.
    Dickinson JC; Durham DG; Hamilton PB
    Invest Ophthalmol; 1968 Oct; 7(5):551-63. PubMed ID: 5682930
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of lipid fractions in prostate gland (author's transl)].
    Tsugaya M; Sugiura H; Otaguro K
    Nihon Hinyokika Gakkai Zasshi; 1979 Oct; 70(10):1049-54. PubMed ID: 93153
    [No Abstract]   [Full Text] [Related]  

  • 26. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
    Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
    Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue fibronectin levels of human prostatic cancer, as a tumor marker.
    Sönmez H; Süer S; Karaarslan I; Baloğlu H; Kökoğlu E
    Cancer Biochem Biophys; 1995 Nov; 15(2):107-10. PubMed ID: 8590435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase of glycerol phosphoryl ethanolamine in human adenocarcinomatous prostate tissue.
    van Sande M; Van Camp K
    J Urol; 1979 Jan; 121(1):133. PubMed ID: 83393
    [No Abstract]   [Full Text] [Related]  

  • 29. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
    Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
    Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
    Kim ED; Smith ND; Grayhack JT
    J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns.
    Janković MM; Kosanović MM
    Clin Biochem; 2005 Jan; 38(1):58-65. PubMed ID: 15607318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Morphological and biochemical studies of collagen in prostatic hypertrophy (author's transl)].
    Nojima T
    Hokkaido Igaku Zasshi; 1981 May; 56(3):291-308. PubMed ID: 6172348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
    Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pepsinogen C in the human prostate].
    Kohout J; Kucerová Z; Korbová L; Simon V; Cypriánová A
    Rozhl Chir; 1989 Feb; 68(2):122-7. PubMed ID: 2470155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraganglion of the prostate in a needle biopsy: a potential diagnostic pitfall.
    Kawabata K
    Arch Pathol Lab Med; 1997 May; 121(5):515-6. PubMed ID: 9167608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective osteoblast mitogens can be extracted from prostatic tissue.
    Koutsilieris M; Rabbani SA; Goltzman D
    Prostate; 1986; 9(2):109-15. PubMed ID: 2428019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated 12- and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases.
    Nithipatikom K; Isbell MA; See WA; Campbell WB
    Cancer Lett; 2006 Feb; 233(2):219-25. PubMed ID: 15882928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation of M3 muscarinic receptor expression in different prostate tissues and its significance.
    Song W; Yuan M; Zhao S
    Saudi Med J; 2009 Aug; 30(8):1010-6. PubMed ID: 19668880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Androgen and estrogen receptors in intact, hyperplastic, peritumorous and malignant prostate tissues: a link to proliferation and apoptosis (immunochemical study)].
    Fedosenko KV; Koval'skiĭ GB
    Vopr Onkol; 2005; 51(2):216-8. PubMed ID: 16223004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactivity of ubiquitin in human prostate gland.
    Bataineh ZM; Habbal O
    Neuro Endocrinol Lett; 2006 Aug; 27(4):517-22. PubMed ID: 16892003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.